Work

All Optimal Dosing Roads Lead to Therapeutic Drug Monitoring—Why Take the Slow Lane

Year: 2022

Type: article

Abstract: This Viewpoint discusses therapeutic drug monitoring as a necessary treatment paradigm and the need for regulatory agencies to provide the conditions to make it happen.

Source: JAMA Oncology

DOI: 10.1001/jamaoncol.2022.4452

Authors: Jan H. Beumer, Edward Chu, Salvatore J. Salamone

Institutions: University of Pittsburgh, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, Albert Einstein College of Medicine, Montefiore Einstein Comprehensive Cancer Center, Saladax Biomedical (United States)

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Awards: NCI ETCTN Pittsburgh Cancer Consortium (PCC), Cancer Center Support Grant, PITT-CAL ETCTN PK Resource Laboratory, Cancer Center Support Grant

OpenAlex ID: W4306884807

FWCI: 2.505

Cites: 8

Cited by: 13

Related to: 10